Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina G Vital

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|January 3, 2017
Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agentsRaul C Maranhão, Carolina G Vital, Thauany M Tavoni, et al.
International Journal of Nanomedicine|October 20, 2010
Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptakeCristina P Almeida, Carolina G Vital, Thais C Contente, et al.
Journal of Bone Oncology|May 6, 2022
Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefitsCarolina G Vital, Raul C Maranhão, Fatima R Freitas, et al.
Chemistry and Physics of Lipids|March 28, 2026
Characterization of Cholesterol-Rich Nanoemulsions (LDE) from Different Lipid Mixtures: A USAXS and DLS Study on Particle Shape and Long-Term StabilityAline S Perez, Juliana L L F Regueira, Carolina G Vital, et al.
Medical Oncology (Northwood, London, England)|July 31, 2017
Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinomaSilvia R Graziani, Carolina G Vital, Aleksandra T Morikawa, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|January 3, 2017
Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agentsRaul C Maranhão, Carolina G Vital, Thauany M Tavoni, et al.
International Journal of Nanomedicine|October 20, 2010
Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptakeCristina P Almeida, Carolina G Vital, Thais C Contente, et al.
Journal of Bone Oncology|May 6, 2022
Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefitsCarolina G Vital, Raul C Maranhão, Fatima R Freitas, et al.
Chemistry and Physics of Lipids|March 28, 2026
Characterization of Cholesterol-Rich Nanoemulsions (LDE) from Different Lipid Mixtures: A USAXS and DLS Study on Particle Shape and Long-Term StabilityAline S Perez, Juliana L L F Regueira, Carolina G Vital, et al.
Medical Oncology (Northwood, London, England)|July 31, 2017
Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinomaSilvia R Graziani, Carolina G Vital, Aleksandra T Morikawa, et al.
Pageof 1